CDC42 and urinary bladder cancer: In this study, we found that cell movement is RAC1-dependent in bladder cancer, and RAC1 activity, but not RhoA and CDC42, is inhibited by RACGAP1, which is partially reversed following SHCBP1 ectopic expression.